Company Description
AVI BioPharma, Inc.. The Company's principal activity is to develop therapeutic products for the treatment of life-threatening diseases using third-generation NEUGENE antisense drugs. NEUGENE drugs used in treatment of cardiovascular disease, ...
More
Related Business Topics
0-9 |
A |
B |
C |
D |
E |
F |
G |
H |
I |
J |
K |
L |
M |
N |
O |
P |
Q |
R |
S |
T |
U |
V |
W |
X |
Y |
Z
A
Breaking News
Reuters - Nov. 19, 2009, 5:59 AM
Reuters - Nov. 18, 2009, 5:43 AM
Times Online - Oct. 20, 2009, 8:10 AM
Get NanoGreens® Direct
Nanogreens® direct from BioPharma ©Official Order Site Nanogreens 10®
MyBioPharmacy.com/Home
Nanogreens® direct from BioPharma ©Official Order Site Nanogreens 10®
MyBioPharmacy.com/Home
Biopharma Reference Book
All US & Euro Biopharmaceuticals New 6th Edition, 1602 Pgs Sept 2007
www.BioPlanAssociates.com/biopharma
All US & Euro Biopharmaceuticals New 6th Edition, 1602 Pgs Sept 2007
www.BioPlanAssociates.com/biopharma
